71027-013 : Oxymetazoline Hcl .5 mg/ml Oral Spray


NDC71027-013
Labeler: Kingston Pharma LLC
Product Type: Human OTC Drug
Drug Name:  Oxymetazoline Hcl
Dosage Form: Oral Spray
Application #: part341
Rev. Date: 


NDC Package Codes:

  • 71027-013-02: 1 BOTTLE IN 1 CARTON (71027‑013‑02) > 30 ML IN 1 BOTTLE
  • 71027-013-17: 1 BOTTLE IN 1 CARTON (71027‑013‑17) > 15 ML IN 1 BOTTLE

Active Ingredients:

  • Oxymetazoline Hydrochloride

Dosage Strength:

  • .5 mg/mL

Related Products:

Based on records with the same trade name.
  • 45802-410 Oxymetazoline Hcl .05 g/100ml Nasal Spray by Perrigo New York Inc
  • 50090-4308 Oxymetazoline Hcl .05 g/100ml Nasal Spray by A-s Medication Solutions
  • 58599-027 Oxymetazoline Hcl .5 mg/ml Oral Spray by Purinepharma LLC
  • 68071-2810 Oxymetazoline Hcl .05 g/100ml Nasal Spray by Nucare Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71027-013 QR Code

< Prev: 71026-011Next: 71027-019 >

Related Discussions:

oxymetazoline eye drops
I think they are selling Visine LR on the internet, but it is very expensive. It is the only gtts that work for me. Have... 2 replies
Oxymetazoline nasal drops could not sleep
Recently bought Oxymetazoline nasal spray. I have COPD emphysema. I spent the whole night coughing with no sleep. Has an... 1 reply
eye drops with oxymetazoline
replacement for Visine LR ## PLEASE IF THERE IS A REPLACEMENT FOR VLR, LET US KNOW ALL THE DETAILS OF THE EYE DROPS ASAP... 111 replies
Replacement for Visine L.R. w/oxymetazoline.
Opcon A eye drops work well for a short time. I haven't found any eye drops to replace Visine L.R. that have the las... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.